Description

Hexarelin is a synthetic hexapeptide and potent ghrelin receptor (GHSR-1a) agonist, structurally related to other growth hormone-releasing peptides (GHRPs). It stimulates the anterior pituitary to release endogenous growth hormone (GH) in a pulsatile manner, mimicking physiological secretion patterns.

In research settings, Hexarelin has demonstrated strong anabolic activity, supporting protein synthesis, muscle growth, and tissue regeneration. It has also been investigated for its effects on bone density, lipid metabolism, and immune function. Unlike some GHRPs, Hexarelin may cause slight elevations in cortisol and prolactin, which are relevant in studies of endocrine modulation.

Additionally, Hexarelin has been of interest in cardiovascular research due to its potential protective effects on cardiac tissue, including anti-apoptotic, anti-fibrotic, and myocardial repair properties observed in preclinical models. Its robust GH-releasing capacity and broader systemic effects make it a valuable compound in regenerative medicine and metabolic health research.